SCHEMBL6983922

SCHEMBL6983922

Cc1c[c]n(S(=O)(=O)c2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.44
PARL Q9H300 1/20 0.42
NPSR1 Q6W5P4 1/20 0.41
POLB P06746 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PKM P14618 2/20 0.39
HTR6 P50406 1/20 0.39
CYP2C9 P11712 2/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
MMP2 P08253 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
ACHE P22303 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
LMNA P02545 1/20 0.37
MCOLN3 Q8TDD5 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1616337 0.68 ALDH1A1 (0.42) PARLNPSR1POLBL3MBTL1PKM
SCHEMBL12569759 0.67 PKM (0.60) GAAPARLNPSR1POLBL3MBTL1
SCHEMBL10466729 0.65 BRD4 (0.47) GAAPARLPOLBL3MBTL1HTR6
SCHEMBL4825070 0.64 CA1 (0.55) GAANPSR1POLBL3MBTL1PKM
SCHEMBL442392 0.64 HTR6 (0.50) PARLL3MBTL1PKMHTR6CYP2C9
SCHEMBL28657726 0.63 ALDH1A1 (0.44) PARLPOLBL3MBTL1HTR6CYP3A4
SCHEMBL11628895 0.63 GAA (0.86) GAAPOLBPKMLMNAALDH1A1
SCHEMBL6985985 0.62 CYP2C9 (0.43) PARLNPSR1POLBL3MBTL1PKM
SCHEMBL2741400 0.62 POLB (0.58) GAAPOLBL3MBTL1PKMCYP2C9
(Phenylsulfonyl)Benzene SCHEMBL6912665 0.61 HTR6 (0.74) GAAPOLBL3MBTL1HTR6CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030181496-A1 Pyrrole derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2003-09-25 US disclosed
EP-1310485-A1 PYRROLE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030181496-A1 Pyrrole derivatives NCOA1, PKD1, NR3C2 GAA 4826/4885PARL 4392/4885NPSR1 2172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.